Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study

Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study

Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2016-07, Vol.34 (34), p.4046-4049
Hauptverfasser: Langley, J.M, MacDougall, D.M, Halperin, B.A, Swain, A, Halperin, S.A, Top, K.A, McNeil, S.A, MacKinnon-Cameron, D, Marty, K, De Serres, G, Dubé, E, Bettinger, J.A
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Age
Allergy and Immunology
Canada
Clinical trials
College campuses
Demographics
Disease
Disease outbreaks
Emergency medical services
Fatalities
Female
Health problems
Health surveillance
Humans
Immunization
Influenza
Internet
Male
Mass Vaccination
Medical research
Meningococcal Infections - prevention & control
Meningococcal Vaccines - administration & dosage
Meningococcal Vaccines - adverse effects
Meningococcal Vaccines - therapeutic use
Neisseria meningitidis
Neisseria meningitidis group B
Neisseria meningitidis, Serogroup B
Population Surveillance
Product Surveillance, Postmarketing
Public health
Regulatory approval
Response rates
Student health services
Students
Surveys and Questionnaires
Universities
Vaccination - adverse effects
Vaccines
Young Adult
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • An online surveillance program for health events following vaccine was launched during a campus outbreak. • Events were reported more frequently in vaccinees than in controls. • Higher rates of medically attended health events in vaccinees and controls than has been reported in clinical trials.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2016.06.025